Medicare Enrolled

Dr. Judy Chang Strepka, MD

Ophthalmology · Houston, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
845 FM 1960 RD W, Houston, TX 77090
2818931760
Registered in NPPES since 2007
NPI: 1659569648 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chang Strepka from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chang Strepka? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chang Strepka

Dr. Judy Chang Strepka is an ophthalmology specialist in Houston, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Chang Strepka performed 3,295 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Chang Strepka received a total of $8,200 from 39 pharmaceutical and/or device companies across 402 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chang Strepka is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years of NPI registration ▲ Top 28% volume in TX $8,200 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
3,295
Medicare services
Top 28% in TX for ophthalmology
Not available
Unique patients (not deduplicated)
$89
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
890 $88 $152
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
643 $66 $106
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
332 $27 $54
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
295 $30 $55
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
266 $47 $85
Corneal topography and eye depth measurement
This procedure measures the curvature and depth of the cornea, the clear front surface of the eye.
214 $32 $109
Cataract surgery with lens implant
Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision.
209 $425 $879
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
134 $90 $182
Laser removal of recurring cataract
A laser procedure to remove a recurring cataract within the lens capsule.
120 $260 $447
Ultrasound scan of cornea to determine thickness
An ultrasound procedure used to measure the thickness of the cornea.
100 $8 $16
Insertion of drug delivery implant into tear duct
A small implant containing medication is placed into the tear duct of the eye to deliver drugs directly to the eye over time.
42 $13 $46
Eye drainage system examination
An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye.
36 $21 $34
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
14 $66 $135
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
6.3% high complexity
22.1% medium
71.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$8,200
Total received (2018-2024)
Avg $1,171/year across 7 years
Top 15% in TX for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
402
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,457
2023
$1,292
2022
$1,305
2021
$1,292
2020
$1,003
2019
$1,010
2018
$840

Payments by company (2024)

Alcon Vision LLC
$397
Bausch & Lomb Americas Inc.
$195
Amgen Inc.
$160
Carl Zeiss Meditec USA, Inc.
$97
ABBVIE INC.
$97
Harrow Eye, LLC
$95
Oyster Point Pharma, Inc.
$79
Tarsus Pharmaceuticals, Inc.
$66
Dompe US, Inc.
$65
Glaukos Corporation
$48
Sight Sciences, Inc.
$39
BIOTISSUE HOLDINGS INC.
$39
Astellas Pharma US Inc
$26
Thea Pharma Inc.
$24
Ocular Therapeutix, Inc.
$18
SUN PHARMACEUTICAL INDUSTRIES INC.
$13
Top 3 companies account for 51.6% of 2024 payments
All-time payments by company (2018-2024) ›
Alcon Vision LLC
$1,149
Bausch & Lomb, a division of Bausch Health US, LLC
$925
Johnson & Johnson Surgical Vision, Inc.
$539
Bausch & Lomb Americas Inc.
$519
Novartis Pharmaceuticals Corporation
$516
Shire North American Group Inc
$515
Oyster Point Pharma, Inc.
$425
AbbVie Inc.
$321
Allergan, Inc.
$290
ABBVIE INC.
$279
Sun Pharmaceutical Industries Inc.
$252
Aerie Pharmaceuticals, Inc.
$247
Ocular Therapeutix, Inc.
$242
Akorn, Inc.
$197
Carl Zeiss Meditec USA, Inc.
$191
Amgen Inc.
$160
Kala Pharmaceuticals, Inc.
$158
Horizon Therapeutics plc
$128
Allergan Inc.
$115
Dompe US, Inc.
$106
Carl Zeiss Meditec, Inc.
$106
Harrow Eye, LLC
$95
Eyevance Pharmaceuticals LLC
$94
Glaukos Corporation
$84
Sight Sciences, Inc.
$73
Tarsus Pharmaceuticals, Inc.
$66
TISSUETECH, INC.
$49
Thea Pharma Inc.
$47
Akorn Operating Company LLC
$44
TissueTech, Inc.
$40
BIOTISSUE HOLDINGS INC.
$39
Mallinckrodt Hospital Products Inc.
$33
SUN PHARMACEUTICAL INDUSTRIES INC.
$31
Astellas Pharma US Inc
$26
GLAUKOS CORPORATION
$25
Merz North America, Inc.
$23
BioTissue Holdings, Inc.
$20
Carl Zeiss Meditec AG
$19
RxSight Inc
$13
Top 3 companies account for 31.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ALPHAGAN P · ALREX · ARGOS · ATLAS 500 · AcrySof · AcrySof IQ VIVITY IOL · AzaSite · BESIVANCE · CEQUA · CEQUA (cyclosporine ophthalmic solution) 0.09% · CIRRUS HD-OCT · COMBIGAN · Centurion · Cequa · Clareon · DEXTENZA · DURYSTA · EYSUVIS · Flarex · Humphrey HFA · INVELTYS · IYUZEH · Izervay · KXL SYSTEM · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LOTEMAX · LOTEMAX GEL · LOTEMAX SM · LUMIGAN · LenSx · MIEBO · NEOX · None Specified · OMNI SURGICAL SYSTEM · OXERVATE · PROKERA · Precision 1 · Prokera · RESTASIS · RESTASIS MULTIDOSE · ReSure Sealant · Rocklatan · Simbrinza · TECNIS IOL · TEPEZZA · TRAVATAN Z · TYRVAYA · TearCare · TearCare SmartLid · Tecnis IOL · Tecnis Multifocal Family of 1-piece IOLS · Tecnis Simplicity · VERITAS Vision System · VEVYE · VUITY · VYZULTA · Whitestar Phacoemulsficiation System · Whitestar Signature · Whitestart Phacoemulsficiation System · XDEMVY · XELPROS · XEOMIN · XIIDRA · Zioptan · iDose · iStent Trabecular Micro-Bypass System Model iS3 · iStent inject Trabecular Micro-Bypass Stent System · rhopressa · rocklatan
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an ophthalmology specialist in Houston?
Compare ophthalmologists in the Houston area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists in nearby ZIP areas
294
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
HCA HOUSTON HEALTHCARE NORTHWEST
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Chang Strepka is a mixed practice specialist, with above-average Medicare volume (top 28% in TX), with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Chang Strepka experienced with comprehensive eye exam, established patient?
Based on Medicare claims data, Dr. Chang Strepka performed 890 comprehensive eye exam, established patient services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Chang Strepka receive payments from pharmaceutical companies?
Yes. Dr. Chang Strepka received a total of $8,200 from 39 companies across 402 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chang Strepka's costs compare to other ophthalmologists in Houston?
Dr. Chang Strepka's average Medicare payment per service is $89. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chang Strepka) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →